SNGX: Interim Analysis of SGX942 in Oral Mucositis in Third Quarter of 2019… – Zacks Small Cap Research

03/29/2019. Download this Report (). By David Bautz, PhD. NASDAQ:SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Interim Analysis in …